. 2018 Apr 21;24(15):1601–1615. doi: 10.3748/wjg.v24.i15.1601
©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
Figure 2.
Summary of OMICs biomarkers in the prediction of nonalcoholic fatty liver disease severity.